Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Paper-Based Diagnostic Test Developed For Diabetes

By LabMedica International staff writers
Posted on 04 Jun 2012
A device has been developed that measures glucose in urine samples and is made from inexpensive materials.

The device consists of three electrodes, a buffer solution, a piece of paper (or nitrocellulose) and a plastic dish. The sample is injected onto the paper with a slightly modified medical syringe, and the solution moves along the paper by gravity and capillary action.

Scientists at the University of Maryland (Baltimore, MD, USA) developed the system to replace current handheld diabetes monitoring devices, which measure glucose levels in blood, which requires a pinprick to a finger, something that could deter patients from taking the measurements. An enzyme called glucose oxidase is already on the paper, and it reacts with glucose in the sample to produce hydrogen peroxide, which is detected by the electrodes. The system can be built quickly, is inexpensive, and it produces results similar to those from a more expensive, commercially available clinical instrument.

Capillary wicking facilitates a gravity-driven flow of buffer solution continuously through paper and nitrocellulose, from a buffer reservoir at one end of the device to a sink at the other. A difference in height between the reservoir and the sink leads to a continuous and constant flow. The nitrocellulose lies horizontally on a working electrode, which consists of a thin platinum layer deposited on a solid support. The counter and reference electrodes are strategically positioned upstream in the buffer reservoir. A simple pipetting device was developed for reliable application of sub-microliter volumes of sample without the need of commercial micropipettes; this device did not damage the nitrocellulose membrane.

The system is based on amperometry, and the measured current is proportional to the glucose concentration. The maximum height of the signal can be directly related to that of a glucose standard. This system can be constructed rapidly, and it is inexpensive. The amplifier that reads out the current from the working electrode costs less than USD 30 for off-the-shelf components. With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, the development of an inexpensive and easy-to-use urine test is ideally suited for such areas.

The authors concluded that other applications of this methodology could be used such as measuring urinary creatinine or lactate concentrations with appropriate enzymes. The system also has the potential for multiplexing, measuring metabolites in series when the sample passes locations where different enzymes have been spotted on the nitrocellulose. It can also be used as a low-cost detector for micro high-performance liquid chromatography for urine, food, or environmental analysis. The study was published on April 5, 2012, in the journal Analytical Chemistry.

Related Links:
University of Maryland



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Uric Acid and Blood Glucose Meter
URIT-10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.